
Sign up to save your podcasts
Or


By James McCormack
4.6
167167 ratings
The podcast currently has 290 episodes available.
The most played episodes among Podcast App listeners.

In episode 629, Jamie and James invite Karenn Chan to the podcast for the first time. We go over the evidence for the very important topic of if and when to stop medications for dementia. We’ll give you all the numbers you need to have informed conversations with patients and caregivers of people with dementia. Have a listen and hopefully you will find the discussion useful. Show Notes Tools For Practice Deprescribing Cholinesterase Inhibitors: Good or bad idea?

In episode 628, Jamie and James invite Jennifer Young back to the podcast to talk about the very important topic of sleep and what to use instead of medications. We go over all the evidence for cognitive behavioural therapy for insomnia and the numbers look pretty impressive. Have a listen and hopefully you will be impressed by the benefit. Show Notes 1) Tools For Practice Enough Evidence to Put One to Sleep: Cognitive behavioural therapy for insomnia 2) Great Insomnia Website Sleepwell

In episode 627, Tina and James again invite Danielle Perry and Caitlin Finley back to the podcast to answer the question, in children with peanut allergy, does oral immunotherapy increase peanut tolerance, and what are the adverse effects? It does work, but it is not a cure, so you need to know the numbers and the important context – you’ll get this from this podcast. Show Notes Tools For Practice A Tough Nut to Crack: Does oral immunotherapy improve outcomes in peanut allergy?

In episode 626, Tina and James invite Caitlin Finley and Danielle Perry to the podcast to discuss the evidence for using hydrocortisone or pimecrolimus for atopic dermatitis in patients under the age of 2. They do work, so check out the podcast for all the numbers and the important context. Show Notes Tools For Practice Itchy Beginnings: Can we calm infant eczema?

In episode 624, James and Mike K invite Tony Nickonchuk to go over all the new evidence we have for the PCSK9 inhibitors. First, we discuss whether or not the evidence addresses the issue of primary versus secondary prevention. We then give you all the numbers and the context you need to allow you to discuss these with your patients. Show Notes Tools For Practice PCSK9 Inhibitors: Cardiovascular prevention panacea or pricey pokes? PEIP Conference Oct 16-17, 2026
The podcast currently has 290 episodes available.

137 Listeners

319 Listeners

545 Listeners

698 Listeners

503 Listeners

108 Listeners

295 Listeners

267 Listeners

3,359 Listeners

28 Listeners

1,154 Listeners

520 Listeners

80 Listeners

376 Listeners

316 Listeners